Ivetić, J.; Dedeić, J.; Milićević, S.; Vidojević, K.; Delić, M.
Comparative Meta-Analysis of Survival, Risk, and Treatment Efficacy in Immunotherapy for Metastatic Melanoma Using Random-, Fixed-, and Mixed-Effects Models. J. Clin. Med. 2025, 14, 5017.
https://doi.org/10.3390/jcm14145017
AMA Style
Ivetić J, Dedeić J, Milićević S, Vidojević K, Delić M.
Comparative Meta-Analysis of Survival, Risk, and Treatment Efficacy in Immunotherapy for Metastatic Melanoma Using Random-, Fixed-, and Mixed-Effects Models. Journal of Clinical Medicine. 2025; 14(14):5017.
https://doi.org/10.3390/jcm14145017
Chicago/Turabian Style
Ivetić, Jelena, Jovana Dedeić, Srđan Milićević, Katarina Vidojević, and Marija Delić.
2025. "Comparative Meta-Analysis of Survival, Risk, and Treatment Efficacy in Immunotherapy for Metastatic Melanoma Using Random-, Fixed-, and Mixed-Effects Models" Journal of Clinical Medicine 14, no. 14: 5017.
https://doi.org/10.3390/jcm14145017
APA Style
Ivetić, J., Dedeić, J., Milićević, S., Vidojević, K., & Delić, M.
(2025). Comparative Meta-Analysis of Survival, Risk, and Treatment Efficacy in Immunotherapy for Metastatic Melanoma Using Random-, Fixed-, and Mixed-Effects Models. Journal of Clinical Medicine, 14(14), 5017.
https://doi.org/10.3390/jcm14145017